Table 2.
Nkx2.5-cre/+ X Zic3flox/flox | ||||||
---|---|---|---|---|---|---|
Stage | Total | Zic3flox/y | Zic3flox/+ | Zic3flox/+; Nkx2.5-cre | Zic3flox/y; Nkx2.5-cre | P-value |
9.5 dpc | 71 | 20 | 16 | 16 | 19 | 0.87 (χ2 = 0.72) |
Post-birth 3 weeks | 154 | 42 | 44 | 34 | 34 | 0.54 (χ2 = 2.15) |
Wnt1-cre/+ X Zic3flox/flox | ||||||
Stage | Total | Zic3flox/y | Zic3flox/+ | Zic3flox/+; Wnt1-cre | Zic3flox/y; Wnt1-cre | P-value |
9.5 dpc | 93 | 26 | 23 | 21 | 23 | 0.9 (χ2 = 0.57) |
Post-birth 3 weeks | 230 | 59 | 57 | 61 | 53 | 0.89 (χ2 = 0.62) |
No observable abnormalities were found in Zic3flox/y; Nkx2.5-cre and Zic3flox/y; Wnt1-cre mutants. P-values were calculated from the χ2 analysis.